J B Chemicals & Pharmaceuticals Ltd. Financials: Quarterly Results
Revenue
1083
Cr.
PAT
197.89
Cr.
EBITDA
268.75
Cr.
J B Chemicals & Pharmaceuticals Ltd. Q4FY25 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 1064.72 | 1084.90 | 1093.94 | 949.48 | 963.49 |
| Total Income From Operations (Cr.) | 1064.72 | 1084.90 | 1093.94 | 949.48 | 963.49 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 268.75 | 280.50 | 272.72 | 194.48 | 220.57 |
| P/L Before Exceptional Items & Tax (Cr.) | 266.87 | 279.15 | 271.61 | 193.03 | 217.99 |
| P/L After Tax from Ordinary Activities (Cr.) | 197.89 | 207.82 | 202.38 | 145.69 | 162.49 |
| Net Profit/Loss For the Period (Cr.) | 197.89 | 207.82 | 202.38 | 145.69 | 162.49 |
| Basic EPS | 12.63 | 13.29 | 12.99 | 9.36 | 10.46 |
FAQs
J B Chemicals & Pharmaceuticals Ltd. announced its quarterly results for Q4 FY2025 on May 15, 2025.
In Q4 FY2025, J B Chemicals & Pharmaceuticals Ltd. are as follows:
Revenue: ₹1083 crore
Net Profit: ₹197.89 crore.
For Q4 FY2025, J B Chemicals & Pharmaceuticals Ltd. posted ₹1083 crore in revenue and ₹197.89 crore in net profit.
Past quarterly results for J B Chemicals & Pharmaceuticals Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.